Leading drugmakers in race for domestic pharmaceutical market

The major drug manufacturers are vying for a bigger share of the domestic market.

These leading pharmaceutical firms, grappling with the government’s policy to abandon rebates, seek to offset part of their dwindling sales by targeting new generic drug market.

Small- and medium-sized drugmakers also look to expand their presence in the domestic medication sector.

According to pharmaceut...